CN Stock MarketDetailed Quotes

000597 Northeast Pharmaceutical Group

Watchlist
  • 5.59
  • -0.18-3.12%
Market Closed Dec 13 15:00 CST
7.99BMarket Cap23.00P/E (TTM)

Northeast Pharmaceutical Group Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Operating Cash Flow
Goods sale service render cash
-5.94%5.88B
-11.87%3.73B
-20.39%1.7B
-5.50%8.48B
-3.31%6.25B
2.17%4.24B
8.72%2.13B
4.93%8.97B
7.29%6.46B
6.35%4.15B
Refunds of taxes and levies
90.37%16.46M
186.04%14.78M
642.38%9.22M
-75.05%9.9M
-59.44%8.65M
-68.61%5.17M
-87.99%1.24M
16.43%39.67M
-22.83%21.32M
4.16%16.46M
Cash received relating to other operating activities
-32.50%223.85M
-33.66%190.65M
-24.16%88.23M
49.35%407.15M
80.37%331.64M
113.50%287.39M
26.15%116.34M
28.08%272.61M
28.99%183.86M
17.81%134.61M
Cash inflows from operating activities
-7.15%6.12B
-13.03%3.94B
-20.22%1.8B
-4.19%8.89B
-1.18%6.59B
5.39%4.53B
9.01%2.25B
5.53%9.28B
7.66%6.67B
6.66%4.3B
Goods services cash paid
2.26%3.53B
-5.44%2.15B
-14.08%999.22M
-0.38%4.78B
-2.22%3.46B
2.53%2.27B
8.55%1.16B
3.35%4.8B
10.88%3.54B
7.74%2.21B
Staff behalf paid
2.29%791.02M
6.71%591.52M
20.95%357.91M
0.51%1.02B
-0.14%773.28M
2.64%554.31M
7.32%295.93M
-6.10%1.02B
-9.22%774.36M
-12.30%540.04M
All taxes paid
-10.52%401.24M
-17.54%268.91M
-9.02%130.7M
19.18%545.56M
39.54%448.42M
52.76%326.13M
27.12%143.67M
2.09%457.76M
-11.43%321.36M
-10.51%213.49M
Cash paid relating to other operating activities
-39.28%962M
-48.20%575.81M
-60.11%212.88M
3.07%1.96B
16.16%1.58B
26.03%1.11B
56.04%533.67M
1.37%1.9B
1.12%1.36B
-6.47%882.07M
Cash outflows from operating activities
-9.16%5.69B
-15.94%3.58B
-20.39%1.7B
1.63%8.31B
4.47%6.26B
10.72%4.26B
18.54%2.14B
1.55%8.17B
4.20%5.99B
-0.07%3.85B
Net cash flows from operating activities
31.42%428.57M
33.65%354.84M
-17.02%94.89M
-47.07%586.75M
-51.52%326.1M
-40.55%265.51M
-56.42%114.35M
48.50%1.11B
52.81%672.68M
154.53%446.62M
Investing cash flow
Net cash received from disposal of fix assets、 intangible assets 、other long-term asset
-95.06%368.99K
-95.06%368.99K
-94.92%377.32K
179.15%7.47M
825.76%7.47M
1,791.43%7.47M
2,150.61%7.43M
-30.25%2.67M
-88.95%806.58K
-91.13%394.78K
Cash inflows from investing activities
-95.06%368.99K
-95.06%368.99K
-94.92%377.32K
179.15%7.47M
825.76%7.47M
1,791.43%7.47M
2,150.61%7.43M
-99.49%2.67M
-88.95%806.58K
-91.13%394.78K
Cash paid to acquire fixed assets intangible assets and other long-term assets
-22.72%136.1M
-12.05%92.66M
38.38%50.24M
-3.56%235.43M
0.18%176.12M
0.12%105.35M
-51.78%36.31M
103.77%244.13M
100.25%175.8M
66.49%105.23M
Cash paid to acquire investments
----
----
----
----
----
----
----
----
--0
----
Cash paid relating to other investing activities
----
----
----
----
----
----
----
-97.02%14.89M
--0
----
Cash outflows from investing activities
-22.72%136.1M
-12.05%92.66M
38.38%50.24M
-9.11%235.43M
0.18%176.12M
0.12%105.35M
-51.78%36.31M
-58.21%259.02M
-70.09%175.8M
-81.32%105.23M
Net cash flows from investing activities
19.52%-135.73M
5.71%-92.29M
-72.66%-49.86M
11.07%-227.96M
3.62%-168.65M
6.63%-97.88M
61.47%-28.88M
-156.15%-256.34M
69.85%-174.99M
81.24%-104.83M
Financing cash flow
Cash received from capital contributions
----
----
----
----
----
----
----
5,781.98%235.28M
6,843.37%208.3M
--500K
-Including: Cash received from capital contributions by minority shareholders of subsidiaries
----
----
----
----
----
----
----
-87.50%500K
-83.33%500K
--500K
Cash from borrowing
-40.56%1.46B
-39.03%707.2M
24.49%560.2M
-9.54%2.76B
6.91%2.46B
-32.60%1.16B
-48.22%450M
-21.30%3.05B
-27.42%2.3B
-31.36%1.72B
Cash received relating to other financing activities
30.19%9.54B
50.45%7.09B
-25.19%1.61B
100.42%11.22B
95.15%7.33B
77.70%4.71B
99.02%2.15B
98.61%5.6B
62.17%3.76B
45.44%2.65B
Cash inflows from financing activities
12.41%11B
32.78%7.8B
-16.59%2.17B
57.35%13.98B
56.25%9.79B
34.29%5.87B
33.35%2.6B
32.61%8.88B
14.13%6.27B
1.00%4.37B
Borrowing repayment
-29.23%1.54B
-51.15%606.03M
73.27%350M
-15.70%2.83B
9.68%2.17B
-8.68%1.24B
-79.02%202M
-17.38%3.36B
-18.14%1.98B
-30.95%1.36B
Dividend interest payment
-16.42%194.32M
-13.57%178.93M
-31.03%17.9M
100.79%219.78M
102.13%232.48M
134.97%207.02M
-19.15%25.95M
-33.87%109.46M
-11.48%115.01M
-10.42%88.1M
-Including:Cash payments for dividends or profit to minority shareholders
-95.30%45.49K
----
----
----
--967.79K
--597.61K
----
----
----
----
Cash payments relating to other financing activities
47.91%9.66B
47.99%6.91B
-21.76%1.6B
92.58%10.55B
86.92%6.53B
75.52%4.67B
88.67%2.05B
110.33%5.48B
40.45%3.49B
35.02%2.66B
Cash outflows from financing activities
27.50%11.39B
25.79%7.69B
-13.42%1.97B
52.05%13.6B
59.88%8.93B
48.94%6.11B
9.35%2.27B
30.91%8.94B
10.98%5.59B
1.75%4.11B
Net cash flows from financing activities
-145.09%-385.86M
145.23%108.58M
-38.63%200.7M
746.08%381.1M
26.36%855.75M
-189.22%-240.07M
353.70%327M
55.45%-58.99M
49.10%677.22M
-9.22%269.09M
Net cash flow
Exchange rate change effecting cash and cash equivalents
-190.94%-8.47M
-68.72%2.78M
160.75%1.43M
-8.94%6.29M
0.60%9.31M
256.21%8.88M
-1,640.36%-2.36M
511.55%6.91M
1,175.38%9.26M
296.62%2.49M
Net increase in cash and cash equivalents
-109.93%-101.49M
688.29%373.91M
-39.74%247.15M
-6.75%746.18M
-13.65%1.02B
-110.36%-63.56M
602.43%410.11M
56.17%800.16M
278.25%1.18B
795.99%613.37M
Add:Begin period cash and cash equivalents
36.93%2.77B
36.93%2.77B
36.93%2.77B
65.55%2.02B
65.55%2.02B
65.55%2.02B
65.55%2.02B
72.34%1.22B
72.34%1.22B
72.34%1.22B
End period cash equivalent
-12.41%2.67B
60.48%3.14B
23.99%3.01B
36.93%2.77B
26.55%3.04B
6.72%1.96B
90.06%2.43B
65.55%2.02B
135.46%2.4B
195.74%1.83B
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
Grant Thornton Certified Public Accountants (Special General Partnership)
--
--
--
Grant Thornton Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Operating Cash Flow
Goods sale service render cash -5.94%5.88B-11.87%3.73B-20.39%1.7B-5.50%8.48B-3.31%6.25B2.17%4.24B8.72%2.13B4.93%8.97B7.29%6.46B6.35%4.15B
Refunds of taxes and levies 90.37%16.46M186.04%14.78M642.38%9.22M-75.05%9.9M-59.44%8.65M-68.61%5.17M-87.99%1.24M16.43%39.67M-22.83%21.32M4.16%16.46M
Cash received relating to other operating activities -32.50%223.85M-33.66%190.65M-24.16%88.23M49.35%407.15M80.37%331.64M113.50%287.39M26.15%116.34M28.08%272.61M28.99%183.86M17.81%134.61M
Cash inflows from operating activities -7.15%6.12B-13.03%3.94B-20.22%1.8B-4.19%8.89B-1.18%6.59B5.39%4.53B9.01%2.25B5.53%9.28B7.66%6.67B6.66%4.3B
Goods services cash paid 2.26%3.53B-5.44%2.15B-14.08%999.22M-0.38%4.78B-2.22%3.46B2.53%2.27B8.55%1.16B3.35%4.8B10.88%3.54B7.74%2.21B
Staff behalf paid 2.29%791.02M6.71%591.52M20.95%357.91M0.51%1.02B-0.14%773.28M2.64%554.31M7.32%295.93M-6.10%1.02B-9.22%774.36M-12.30%540.04M
All taxes paid -10.52%401.24M-17.54%268.91M-9.02%130.7M19.18%545.56M39.54%448.42M52.76%326.13M27.12%143.67M2.09%457.76M-11.43%321.36M-10.51%213.49M
Cash paid relating to other operating activities -39.28%962M-48.20%575.81M-60.11%212.88M3.07%1.96B16.16%1.58B26.03%1.11B56.04%533.67M1.37%1.9B1.12%1.36B-6.47%882.07M
Cash outflows from operating activities -9.16%5.69B-15.94%3.58B-20.39%1.7B1.63%8.31B4.47%6.26B10.72%4.26B18.54%2.14B1.55%8.17B4.20%5.99B-0.07%3.85B
Net cash flows from operating activities 31.42%428.57M33.65%354.84M-17.02%94.89M-47.07%586.75M-51.52%326.1M-40.55%265.51M-56.42%114.35M48.50%1.11B52.81%672.68M154.53%446.62M
Investing cash flow
Net cash received from disposal of fix assets、 intangible assets 、other long-term asset -95.06%368.99K-95.06%368.99K-94.92%377.32K179.15%7.47M825.76%7.47M1,791.43%7.47M2,150.61%7.43M-30.25%2.67M-88.95%806.58K-91.13%394.78K
Cash inflows from investing activities -95.06%368.99K-95.06%368.99K-94.92%377.32K179.15%7.47M825.76%7.47M1,791.43%7.47M2,150.61%7.43M-99.49%2.67M-88.95%806.58K-91.13%394.78K
Cash paid to acquire fixed assets intangible assets and other long-term assets -22.72%136.1M-12.05%92.66M38.38%50.24M-3.56%235.43M0.18%176.12M0.12%105.35M-51.78%36.31M103.77%244.13M100.25%175.8M66.49%105.23M
Cash paid to acquire investments ----------------------------------0----
Cash paid relating to other investing activities -----------------------------97.02%14.89M--0----
Cash outflows from investing activities -22.72%136.1M-12.05%92.66M38.38%50.24M-9.11%235.43M0.18%176.12M0.12%105.35M-51.78%36.31M-58.21%259.02M-70.09%175.8M-81.32%105.23M
Net cash flows from investing activities 19.52%-135.73M5.71%-92.29M-72.66%-49.86M11.07%-227.96M3.62%-168.65M6.63%-97.88M61.47%-28.88M-156.15%-256.34M69.85%-174.99M81.24%-104.83M
Financing cash flow
Cash received from capital contributions ----------------------------5,781.98%235.28M6,843.37%208.3M--500K
-Including: Cash received from capital contributions by minority shareholders of subsidiaries -----------------------------87.50%500K-83.33%500K--500K
Cash from borrowing -40.56%1.46B-39.03%707.2M24.49%560.2M-9.54%2.76B6.91%2.46B-32.60%1.16B-48.22%450M-21.30%3.05B-27.42%2.3B-31.36%1.72B
Cash received relating to other financing activities 30.19%9.54B50.45%7.09B-25.19%1.61B100.42%11.22B95.15%7.33B77.70%4.71B99.02%2.15B98.61%5.6B62.17%3.76B45.44%2.65B
Cash inflows from financing activities 12.41%11B32.78%7.8B-16.59%2.17B57.35%13.98B56.25%9.79B34.29%5.87B33.35%2.6B32.61%8.88B14.13%6.27B1.00%4.37B
Borrowing repayment -29.23%1.54B-51.15%606.03M73.27%350M-15.70%2.83B9.68%2.17B-8.68%1.24B-79.02%202M-17.38%3.36B-18.14%1.98B-30.95%1.36B
Dividend interest payment -16.42%194.32M-13.57%178.93M-31.03%17.9M100.79%219.78M102.13%232.48M134.97%207.02M-19.15%25.95M-33.87%109.46M-11.48%115.01M-10.42%88.1M
-Including:Cash payments for dividends or profit to minority shareholders -95.30%45.49K--------------967.79K--597.61K----------------
Cash payments relating to other financing activities 47.91%9.66B47.99%6.91B-21.76%1.6B92.58%10.55B86.92%6.53B75.52%4.67B88.67%2.05B110.33%5.48B40.45%3.49B35.02%2.66B
Cash outflows from financing activities 27.50%11.39B25.79%7.69B-13.42%1.97B52.05%13.6B59.88%8.93B48.94%6.11B9.35%2.27B30.91%8.94B10.98%5.59B1.75%4.11B
Net cash flows from financing activities -145.09%-385.86M145.23%108.58M-38.63%200.7M746.08%381.1M26.36%855.75M-189.22%-240.07M353.70%327M55.45%-58.99M49.10%677.22M-9.22%269.09M
Net cash flow
Exchange rate change effecting cash and cash equivalents -190.94%-8.47M-68.72%2.78M160.75%1.43M-8.94%6.29M0.60%9.31M256.21%8.88M-1,640.36%-2.36M511.55%6.91M1,175.38%9.26M296.62%2.49M
Net increase in cash and cash equivalents -109.93%-101.49M688.29%373.91M-39.74%247.15M-6.75%746.18M-13.65%1.02B-110.36%-63.56M602.43%410.11M56.17%800.16M278.25%1.18B795.99%613.37M
Add:Begin period cash and cash equivalents 36.93%2.77B36.93%2.77B36.93%2.77B65.55%2.02B65.55%2.02B65.55%2.02B65.55%2.02B72.34%1.22B72.34%1.22B72.34%1.22B
End period cash equivalent -12.41%2.67B60.48%3.14B23.99%3.01B36.93%2.77B26.55%3.04B6.72%1.96B90.06%2.43B65.55%2.02B135.46%2.4B195.74%1.83B
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------Grant Thornton Certified Public Accountants (Special General Partnership)------Grant Thornton Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CN
Overall
Symbol
Price
% Chg

No Data

Investment Theme Revitalizing Tohoku
Revitalizing Tohoku
Intraday-1.63%
Superfungus
Superfungus
Intraday-1.74%
Pharmaceutical E-commerce
Pharmaceutical E-commerce
Intraday-1.88%